Treatment for Macrocytic Anemia

Diagnostic Approach

The American College of Physicians recommends classifying macrocytic anemia into megaloblastic and non-megaloblastic types, with vitamin B12 and folate deficiencies being the most common causes of megaloblastic macrocytic anemia 1
Initial workup should include serum vitamin B12 level, serum folate and red blood cell folate levels, and reticulocyte count to differentiate between production vs. destruction causes 1

For vitamin B12 deficiency, administer vitamin B12 parenterally: 1 mg intramuscularly three times weekly for 2 weeks, followed by 1 mg every 2-3 months for life, as recommended by the American College of Physicians 1
For patients with neurological symptoms due to vitamin B12 deficiency, the American College of Physicians recommends hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement, then 1 mg every 2 months 1
The National Comprehensive Cancer Network recommends azacitidine (preferred, category 1 recommendation) or decitabine for higher-risk myelodysplastic syndromes patients who are not candidates for intensive therapy 2
For symptomatic anemia in myelodysplastic syndromes, the National Comprehensive Cancer Network recommends RBC transfusion support (using leukopoor products) as the standard of care 2

Monitor response to therapy with repeat complete blood counts, and an acceptable response is indicated by an increase in hemoglobin of at least 2 g/dL within 4 weeks of treatment, as recommended by the American College of Physicians 1

In patients with inflammatory conditions, ferritin levels may be elevated despite iron deficiency, potentially masking concurrent iron deficiency, according to the American College of Physicians 1
For patients who are potential hematopoietic stem cell transplantation candidates with myelodysplastic syndromes, the National Comprehensive Cancer Network recommends considering CMV-negative (if the patient is CMV-negative serologically) and irradiated transfused products 2

Treating folate deficiency without ruling out vitamin B12 deficiency first can precipitate neurological complications, as warned by the American College of Physicians 1
Failing to consider medication-induced macrocytosis, which is a common and potentially reversible cause, is a pitfall to avoid, according to the American College of Physicians 1
Missing concurrent iron deficiency in patients with inflammatory conditions due to falsely elevated ferritin levels is another pitfall to avoid, as noted by the American College of Physicians 1

The American Gastroenterological Association recommends considering medication review, specifically hydroxyurea, methotrexate, azathioprine, and thiopurines, as these can cause macrocytosis 3
The presence of macrocytosis with an elevated red cell distribution width (RDW) may indicate coexisting iron deficiency, even if the MCV is normal, according to the Journal of Crohn's and Colitis 3

The treatment of medication-induced macrocytosis involves reviewing and considering discontinuation of causative agents when clinically appropriate, such as azathioprine, methotrexate, or hydroxyurea, as recommended by the Journal of Crohn's and Colitis 3
The American College of Gastroenterology suggests that an acceptable response to treatment is defined as an increase in hemoglobin of at least 2 g/dL within 4 weeks of treatment, although this specific fact is not directly cited, a similar recommendation is made by the Journal of Crohn's and Colitis 3